Legend Biotech (LEGN) Current Taxes (2020 - 2026)
Legend Biotech's (LEGN) quarterly Current Taxes came in at $20.3 million in Q1 2026, up 44.91% YoY from $14.0 million in Q1 2025, and up 5.73% on a QoQ basis from $19.2 million in Q4 2025.
Legend Biotech (LEGN) Current Taxes (2020 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 7 years of Current Taxes data on file, last reported at $20.3 million in Q1 2026.
- Quarterly Current Taxes rose 44.91% year-over-year to $20.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.3 million (up 44.91% YoY) and the FY2025 annual result came in at $19.2 million, down 7.25% from the prior year.
- Current Taxes grew to $20.3 million in Q1 2026, from $19.2 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $20.7 million in Q4 2024 to a low of $6.6 million in Q2 2024.
- A 5-year average of $11.8 million and a median of $10.1 million in 2025 frame the typical range for Current Taxes.
- The widest YoY moves for Current Taxes: up 187.38% in 2024, down 36.41% in 2024.
- Tracing LEGN's Current Taxes over 5 years: stood at $9.8 million in 2022, then fell by 26.29% to $7.2 million in 2023, then surged by 187.38% to $20.7 million in 2024, then declined by 7.25% to $19.2 million in 2025, then grew by 5.73% to $20.3 million in 2026.
- The last three Current Taxes figures came in at $20.3 million (Q1 2026), $19.2 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.70 Mn |
| Mar 31, 2026 | 20.30 Mn |
| Dec 31, 2025 | 19.20 Mn |
| Sep 30, 2025 | 10.11 Mn |
| Jun 30, 2025 | 11.55 Mn |
| Mar 31, 2025 | 14.01 Mn |
| Dec 31, 2024 | 20.70 Mn |
| Sep 30, 2024 | 11.07 Mn |
| Jun 30, 2024 | 6.57 Mn |
| Mar 31, 2024 | 7.27 Mn |
| Dec 31, 2023 | 7.20 Mn |
| Sep 30, 2023 | 9.85 Mn |
| Jun 30, 2023 | 10.33 Mn |
| Mar 31, 2023 | 9.94 Mn |
| Dec 31, 2022 | 9.77 Mn |
| Mar 31, 2022 | 9.57 Mn |
| Dec 31, 2021 | 9.49 Mn |
| Dec 31, 2020 | 8.80 Mn |